Pipeline
Developing promising new therapies for patients with rare genetic diseases.
BioMarin is actively pursuing strategies to enhance its exciting product portfolio. The company has a growing product pipeline, with multiple clinical and nonclinical IND (Investigational New Drug) candidates in development.
Click on the pipeline to learn more about each product candidate.
